Gene Query: MRPL48

Dataset Description Geneva Score
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 22.33
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 17.35
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 16.63
HNF1A deficiency impairs β-cell fate, granule maturation and function 13.83
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 12.34
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 10.88
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 10.24
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 9.99
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.65
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 9.46
Cleavage Factor Im as a key regulator of 3’ UTR length 9.04
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 8.74
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 8.66
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.25
Global analysis of enhancer targets: Mosaic-seq 8.21
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 8.15
Generating Patterned Kidney Organoids for Studying Development and Diseases 8.03
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.98
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 7.86
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 7.59
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 7.39
RNA-seq of YB5 cells treated with Proscillaridin A 7.17
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 7.16
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.13
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 7.13
CROP-Seq in Primary Human T Cells 6.96
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.58
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.58
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.58
In situ CAPTURE of chromatin interactions by biotinylated dCas9 6.42
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 6.42
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 6.37
scRNASeq analysis of cycling cardiomyocytes 6.37
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 6.31
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 6.3
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 6.21
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.02
Genome-wide analysis of the Integrator complex (HTS) 5.74
Genome-wide analysis of the Integrator complex 5.74
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 5.74
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 5.68
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.63
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 5.58
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.51
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 5.51
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 5.47
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 5.47
Gene expression analysis of the impact of TDP-43 knockout in human cells. 5.4
Transcriptomic analysis of human tonsillar TFH subsets 5.29
Hijacking of stress response machinery by oncogenes in acute leukaemia 5.29
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 5.29
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 5.22
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 5.21
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 5.21
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 5.12
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 5.05
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 5.05
Expression by CD133+ cells isolated from the adult human exocrine pancreas 5.05
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.03
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.98
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 4.91
Systematic discovery of endogenous human ribonucleoprotein complexes 4.91
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 4.88
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 4.8
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.77
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 4.67
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.66
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.66
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.62
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.55
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.47
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 4.39
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 4.39
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.36
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 4.32
Identification of renal resident macrophages across species 4.31
Single-cell analysis of adult human ovary using 10X genomics 4.28
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.28
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.26
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 4.2
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 4.2
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 4.2
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 4.14
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 4.09
Impact of dieldrin on transcription in Jurkat T cells 4.07
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.05
Effect of CHKA knockdown on C4-2 cell transcriptome 3.99
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 3.96
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 3.95
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 3.9
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 3.86
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.82
TT-Seq captures the human transient transcriptome 3.82
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 3.76
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.73
Genetic-to-epigenetic Therapy for Pancreatic Cancer 3.72
RNAseq of HEK293 cells after Chtop knockdown 3.72
Co-transcriptional loading of RNA export factors shapes the human transcriptome 3.72
DART-seq: an antibody-free method for global m6A detection 3.71
Human neutrophil genome during PMA- and E. coli encounter-induced activation 3.7
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 3.7
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.7
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 3.66
T47D RNA-seq and ChrRNA-seq data 3.66
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.66
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.65
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 3.62
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.62
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 3.59
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 3.58
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 3.58
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 3.54
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 3.52
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.47
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 3.45
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 3.45
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 3.43
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 3.42
Transcriptome analysis of SKI knock-out in HL60 cells 3.38
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.38
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.36
Targeting MTHFD2 in Acute Myeloid Leukemia 3.36
Rorc disruption in human FG pancreatic cancer cells 3.31
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.3
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 3.28
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 3.28
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.28
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.28
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.27
The comparison of high-throughput single-cell RNA-seq methods 3.27
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.24
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 3.24
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 3.23
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 3.23
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 3.22
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 3.21
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.2
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 3.17
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 3.17
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 3.17
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.16
Solid phase chemistry to covalently and reversibly capture thiolated RNA 3.13
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.09
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.09
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 3.08
ARID1A regulates condensin II distribution and chromosomal partition 3.08
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.08
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 3.06
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.05
Cajal bodies are linked to genome conformation 3.04
Cajal bodies are linked to genome conformation [RNA-Seq] 3.04
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 3.03
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.02
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.02
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 3.02
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 3.0
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 2.99
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.98
Accurate annotation of human protein-coding small open reading frames 2.97
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 2.97
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 2.97
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 2.92
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 2.92
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 2.91
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 2.9
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 2.9
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 2.9
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 2.89
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 2.87
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 2.85
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 2.84
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 2.84
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.82
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.81
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 2.8
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.79
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 2.79
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.75
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.75
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 2.71
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.7
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.7
A novel target of EZH1/2 for treatment of mantle cell lymphoma 2.7
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 2.7
A transcriptome-wide divergence in protein translation scales with LIN28B expression 2.69
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 2.67
RNA-Seq of PRMT1 overexpression ECA109 cells 2.67
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 2.64
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.63
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 2.63
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 2.63
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.6
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 2.58
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 2.56
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.56
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.55
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.55
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 2.54
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 2.54
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.51
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.51
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.5
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 2.5
Transcriptome sequencing of K-562 cells 2.48
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 2.47
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.46
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.46
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.46
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 2.43
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.42
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.42
Landscape and variation of RNA secondary structure across the human transcriptome 2.41
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.4
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.39
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.39
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.37
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.37
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 2.36
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 2.36
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.34
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.34
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.33
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.33
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.33
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.32
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.29
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 2.28
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.28
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.28
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.28
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.28
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 2.25
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 2.25
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.25
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.25
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.22
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.21
Regulation of protein translation during mitosis 2.21
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.2
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 2.19
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.17
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.15
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.14
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.12
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.1
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.09
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 2.07
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.05
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.05
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.04
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 2.04
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.04
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.03
Ribosome profiling upon inhibition of eIF4A 2.03
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 2.02
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.02
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.02
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.0
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.99
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 1.98
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.98
HEK293 TFAM Knockout Expression Study 1.96
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.94
Effect of PBK knockdown on C4-2 cell transcriptome 1.93
RNA-seq of naive and primed ES cells 1.93
Transcriptional landscape changes during human embryonic stem cell derivation 1.93
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 1.92
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.92
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.92
The bromodomain protein BRD4 regulates splicing during heat shock 1.91
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.89
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 1.86
Unique features and clinical importance of acute alloreactive immune responses 1.83
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.81
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.8
Gene expression signatures of innate lymphoid cells from human blood 1.77
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.76
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.72
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.71
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.71
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.7
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.67
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.67
Polarized B -cell functions 1.66
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 1.66
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.65
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 1.65
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.65
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.64
Role of FGFR1 in neuronal devlopment 1.62
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.57
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.54
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.54
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.54
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.53
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.53
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.52
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.51
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.51
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 1.5
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 1.5
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.47
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.46
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.45
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.44
Metastasis in triple-negative breast cancer 1.44
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.42
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.41
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.4
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.4
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 1.39
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 1.39
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.38
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.38
Transcriptional profiling of microglia; current state of the art and future perspectives 1.37
Ribosomal protein RPL26 is the principal target of UFMylation 1.37
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.37
Effect of PRDM11 depletion in U2932 cells 1.37
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.36
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.35
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.34
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.32
RNA-seq of IL-4 stimulated human keratinocytes 1.32
An integrative analysis of non-coding regulatory DNA variations associated with autism 1.3
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 1.3
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.29
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.29
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.29
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.27
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.26
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.26
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.26
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.24
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.23
Human Treg IL-12 stimulation 1.23
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.22
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.2
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.2
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.19
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 1.14
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 1.14
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.13
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.11
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.1
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.1
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.09
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.09
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.09
Single-Cell Genotyping of Transcriptomes 1.09
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.09
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.09
Capturing the Interactome of Newly Transcribed RNA 1.08
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.08
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.08
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.08
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.08
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.04
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 1.04
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 1.04
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.02
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.02
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.02
SF3B1 Degron knockdown RNA-seq 1.01
Functional significance of the HIV-1 Tat signature amino acid residues 1.01
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 0.99
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.96
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.93
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.91
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.89
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.88
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.88
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.87
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.87
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.87
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.86
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.85
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.84
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.84
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.83
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.83
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 0.83
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.82
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.82
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.81
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.81
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.8
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.8
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.8
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.8
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.79
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 0.79
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.79
Effect of drugs on transcriptomic profiles 0.78
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.78
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.77
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 0.76
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.75
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.75
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 0.73
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.73
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.73
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.73
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.72
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.72
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.71
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.71
The cohesin complex prevents Myc-induced replication stress 0.7
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.7
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.69
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.69
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.69
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.64
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.64
Gene expression changes after LOC550643 silencing 0.64
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.64
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.6
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.59
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.59
Single-cell analysis of human kidney organoids 0.59
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.58
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.57
O-glcnAc reprograms cellular energetics 0.57
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.56
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.56
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.56
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.55
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.54
K562 polyA RNA-Seq 0.52
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.51
High-resolution comparative analysis of great ape genomes 0.51
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.5
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.5
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.48
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.48
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.47
U2AF1 mutations alter splice site recognition in hematological malignancies 0.47
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.45
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.44
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.44
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.44
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.43
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.43
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.43
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.42
miRNAs affected by antagomiR-17 treatment 0.42
RNA-seq data 0.42
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.41
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.41
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.4
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.37
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.37
Impact on erythroid progenitor type on erythroid differntiation 0.36
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.35
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.35
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.35
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.34
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.34
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.33
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.31
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.31
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.23
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.23
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.23
Interphase condensins regulate ligand-depedent enhancer activation 0.23
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.23
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.22
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.21
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.21
SLAM-seq for K562 endogenous mRNA decay 0.2
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.2
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.18
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.17
Human Treg IFNg/IL-10 subpopulations 0.15
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.15
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.14
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.14
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.13
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.12
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.11
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.11
Transcriptome-wide modulation of splicing by the exon junction complex 0.1
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.09
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.09
Gene expression changes due to PARP knockdown in human cells 0.09
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.08
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.07
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.07
RNA seq with AML (NB4) cells upon FTO inhibition 0.07
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.07
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.07
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.05
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.04
Expression profiling of MCF-7 cells with treatment of TCDD 0.04
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.04
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.02
RNA-Seq of the corpus callosum from 12 individuals 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.01
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation